Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...
Larian Studios is apparently bullish on generative AI. Despite backlash against the technology from fans and even some of his own developers, studio head Swen Vincke says the Baldur’s Gate 3 maker has ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best NASDAQ stocks under $10 to buy. As of December 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) has a ‘Hold’ or equivalent rating from ...
Cathie Wood’s ARK ETF published their daily trades for Friday, December 19th, 2025, showcasing significant activity in several key stocks. Leading the trades was a substantial sale of 23,110 shares of ...
In 2015, AI in drug discovery was still a theoretical pursuit – exciting, but unproven. A few early start-ups were applying deep learning to virtual screening and molecular modelling, but the industry ...
AI is moving fast and bringing a whole new vocabulary with it. This glossary will help you stay up-to-date. Imad is a senior reporter covering Google and internet culture. Hailing from Texas, Imad ...
Regulators said they would look at whether the deal for Manus, a Singapore start-up with Chinese roots, complied with China’s export and investment rules. By Meaghan TobinXinyun Wu and Eli Tan ...
"Data As Of" refers to the Closing Sale. Volume is updated throughout the after hours market. Note: Daily closing values are valid as of 5:15 p.m. ET. Duplicate values disseminated after 5:15 p.m. ET.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback